Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Almirall to Participate in the 41st Annual J.P. Morgan Healthcare Conference: https://mms.businesswire.com/media/20221109006035/en/1631769/5/ALM_AW_LOGO_Tagline_MV_Positive_RGB_%281%29.jpg
Almirall to Participate in the 41st Annual J.P. Morgan Healthcare Conference


Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, today announced that it will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San

BusinessWire_EN 
0 04.01.23
Almirall’s Nine-month 2022 Results: https://mms.businesswire.com/media/20221109006035/en/1631769/5/ALM_AW_LOGO_Tagline_MV_Positive_RGB_%281%29.jpg
Almirall’s Nine-month 2022 Results


Almirall, S.A. (ALM), the global biopharmaceutical company based in Barcelona, has announced its 9M 2022 financial results.



Financial highlights (€ rounded million)


 


9M 2022

BusinessWire_EN 
0 10.11.22
Edison Investment Research Limited: Oryzon Genomics (ORY): Planning iadademstat's path to market
Edison Investment Research Limited: Oryzon Genomics (ORY): Planning iadademstat's path to market
Edison Investment Research Limited: Oryzon Genomics (ORY): Planning iadademstat's path to market
eqs_en 
0 10.02.22